United States

Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

1 Dec 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Fri, Nov 18 2016

BRIEF-Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln

* Reported on Thursday Q3 operating revenues of 3.6 million Norwegian crowns ($420,000) versus 16.6 million crowns year ago

BRIEF-Hofseth Biocare reports final results of Subsequent Offering

* Said on Monday the subscription period for the Subsequent Offering had ended

BRIEF-Hofseth Biocare receives patent in the European Union

* Announces grant of its European patent application no. 08861633.9 for compositions and methods for increasing iron absorption Source text for Eikon:

BRIEF-Hofseth Biocare Q2 operating loss widens to NOK 47.5 million

* Q2 operating revenue 8.2 million Norwegian crowns ($989,848) versus 6.4 million crowns year ago

BRIEF-Hofseth biocare announces equity issue of minimum NOK 165 mln

* Announces an equity issue of minimum 165 million Norwegian crowns ($20 million) at a subscription price of 1.50 per share crown

BRIEF-Hofseth Biocare: OmeGo patent notice of allowance in US and new study on ProGo

* US patent office has issued a Notice of Allowance on one of HBC's key licensed-in salmon oil patent applications

Select another date: